Researchers find new method to determine blood clot risks

Predicting when a patient is at risk for developing a blood clot can be challenging for physicians, but new research from Johns Hopkins University and Ohio State University delivers a method for precisely identifying those risk factors.

The study, published in the International Journal of Cardiology, presented findings based on simulations performed using the Stampede supercomputer at the Texas Advanced Computing Center in Austin, Texas, and data from patients who did and did not experience post-heart attack blood clots.

Study results showed that a critical factor in predicting risk factors for clots is the degree to which the mitral jet, a blood shot through the mitral valve, penetrates the left ventricle. Without the blood travelling deep enough, the heart may not properly flush out blood from the chamber, resulting in clots, stroke and other dangerous heart events.

"The beauty of the index is that it doesn't require any additional measurements,” said Rajat Mittal, one of the lead authors on the study and a computational fluid dynamics expert and professor of engineering at Johns Hopkins University, in a statement. “It simply reformulates echocardiogram data into a new metric. The clinician doesn't have to do any additional work."

Mittal and his team examined detailed measurements from 13 patients and used them to construct high-fidelity, patient-specific models of the heart. The models included fluid flow, physical structures and bio-chemistry.

"Because we understood the fluid dynamics in the heart using our computational models, we reached the conclusion that the ejection fraction is not a very accurate measure of flow stasis in the left ventricle," Mittal said. "We showed very clearly that the ejection fraction is not able to differentiate a large fraction of these patient and stratify risk, whereas this e-wave propagation index can very accurately stratify who will get a clot and who will not.”

Katherine Davis,

Senior Writer

As a Senior Writer for TriMed Media Group, Katherine primarily focuses on producing news stories, Q&As and features for Cardiovascular Business. She reports on several facets of the cardiology industry, including emerging technology, new clinical trials and findings, and quality initiatives among providers. She is based out of TriMed's Chicago office and holds a bachelor's degree in journalism from Columbia College Chicago. Her work has appeared in Modern Healthcare, Crain's Chicago Business and The Detroit News. She joined TriMed in 2016.

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.